-

$undefined

N/A

(N/A)

Vigil Neuroscience NASDAQ:VIGL

Location: | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

25.77M

Cash

111.3M

Avg Qtr Burn

-12.15M

Short % of Float

8.19%

Insider Ownership

20.70%

Institutional Own.

77.91%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Iluzanebart (VGL101) Details Adult onset leukoencephalopathy w/ axonal spheroids & pigmented glia	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VG-3927 (TREM2 agonist) Details Neurodegenerative disease, Alzheimer's disease	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.